News Feed Opinion Blog Posts Career Updates Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
September, 2025
September 2025
M T W T F S S
1234567
891011121314
15161718192021
22232425262728
2930  
Yüksel Ürün: FDA approves neoadjuvant and adjuvant durvalumab in MIBC
Yüksel Ürün/X
Mar 30, 2025, 16:44

Yüksel Ürün: FDA approves neoadjuvant and adjuvant durvalumab in MIBC

Yüksel Ürün, Medical Oncology professor at Ankara University School of Medicine, shared a post on X:

“Big win for bladder cancer care!

FDA approves neoadjuvant and adjuvant durvalumab (NIAGARA trial) in MIBC!

Chemo and immunotherapy before surgery. Immunotherapy after.

PFS and OS both improved.

Proud to be one of investigator of this milestone!”

Yüksel Ürün: FDA approves neoadjuvant and adjuvant durvalumab in MIBC

More posts featuring Yüksel Ürün.

bladder cancer cancer FDA MIBC NIAGARA trial OncoDaily Oncology Yüksel Ürün
Special Coverage
Voices
Sep 4, 2025, 11:39
Lacy Hubbard: Honored to Join the RSOG 11th Annual Scientific Conference
Voices
Sep 4, 2025, 09:26
Kevin Lo: A Touch of Pink for a Powerful Purpose
Science
Sep 4, 2025, 09:19
Elisa De Paolis: NRG1 VUS Network Analysis and Prognostic Role in EGFR-Mutant NSCLC
FDA Approvals
Sep 4, 2025, 09:08
FDA Grants Breakthrough Therapy Designation to Zongertinib (HERNEXEOS) for First-Line Treatment of HER2-Mutant Advanced NSCLC
Voices
Sep 4, 2025, 09:05
What Problems We’re Addressing and How We’re Supporting Children with Cancer - World Child Cancer USA
Insight
Sep 4, 2025, 08:53
Register Now for ASGCR 2025 Select Sessions - NCI Center for Global Health
Voices
Sep 4, 2025, 08:49
Rob Winn: Ovarian Cancer Awareness Month - Raising Awareness to Change the Future
Voices
Sep 4, 2025, 08:36
Zainab Shinkafi-Bagudu: Delivering Cancer Education at NISS Health Week
Voices
Sep 4, 2025, 08:36
Thoracic Circle is Live! - IASLC
Voices
Sep 4, 2025, 08:27
Breast Cancer Treatment in Low-resource Countries - The Max Foundation
Insight
Sep 4, 2025, 08:13
Society for Integrative Oncology Released New Integrative Oncology eBook
Science
Sep 4, 2025, 08:13
Neil Iyengar: New Report on GLP1 Receptor Agonist Use in Breast Cancer Survivors